| | Insulin Potentiation Therapy |
 | | Insulin potentiation therapy (IPT), a therapy developed in the 1930s in Mexico by Donato Perez Garcia, Sr, MD, uses insulin as an adjunctive agent to potentiate the effects of pharmacologic therapy in the treatment of cancer, infectious diseases, chronic degenerative disorders, and many other conditions. |
 | | The physiologic effects of insulin in IPT are thought to increase the permeability of cell membranes and facilitate increased intracellular absorption of pharmacologic agents. |
 | | IPT is primarily used in the treatment of cancer, for which increasing the intracellular concentration and cytotoxic effects of chemotherapy agents while decreasing the adverse affects is thought to increase antitumoral activity and patient tolerance to treatment. |
| www.regence.com /trgmedpol/medicine/med124.html (672 words) |